Stock listing
North China Pharmaceutical Company Ltd. Class A
Selected listing: 600812 · SSE · CNY · CN
North China Pharmaceutical Company Ltd. Class A (Shanghai:600812), Health Technology. Latest release Sep 10, 2026: "North China Pharmaceutical Company…
- Ticker
- Shanghai:600812
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About North China Pharmaceutical Company Ltd. Class A
North China Pharmaceutical Company Ltd. Class A, traded under the ticker 600812, is a public company based in China.
Latest news from North China Pharmaceutical Company Ltd. Class A
"North China Pharmaceutical Company Ltd."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hebei Jurisdiction and 2026 Semi-annual Collective Performance Briefing
September 9, 2026
"North China Pharmaceutical Company Ltd."Announcement on Providing Guarantees for Subsidiaries
September 2, 2026
"North China Pharmaceutical Company Ltd."Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subordinate Company
August 27, 2026
"North China Pharmaceutical Company Ltd."Semi-annual Report for 2026
August 21, 2026
"North China Pharmaceutical Company, Ltd."Announcement on Resignation of Senior Management
August 5, 2026
Research North China Pharmaceutical Company Ltd. Class A
North China Pharmaceutical Company Ltd. Class A company profile
View the public company page for North China Pharmaceutical Company Ltd. Class A on 6ix.
North China Pharmaceutical Company Ltd. Class A news
Read company news and market updates connected to North China Pharmaceutical Company Ltd. Class A.
North China Pharmaceutical Company Ltd. Class A investor events
Find investor webinars, events, and replay context for North China Pharmaceutical Company Ltd. Class A.